0001209191-20-060227.txt : 20201124 0001209191-20-060227.hdr.sgml : 20201124 20201124164253 ACCESSION NUMBER: 0001209191-20-060227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201123 FILED AS OF DATE: 20201124 DATE AS OF CHANGE: 20201124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sepp-Lorenzino Laura CENTRAL INDEX KEY: 0001777421 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39536 FILM NUMBER: 201344674 MAIL ADDRESS: STREET 1: C/O INTELLIA THERAPEUTICS, INC. STREET 2: 40 ERIE STREET, SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2280 INWOOD ROAD CITY: DALLAS STATE: TX ZIP: 75235 BUSINESS PHONE: (214) 612-0000 MAIL ADDRESS: STREET 1: 2280 INWOOD ROAD CITY: DALLAS STATE: TX ZIP: 75235 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-23 0 0001806310 Taysha Gene Therapies, Inc. TSHA 0001777421 Sepp-Lorenzino Laura C/O TAYSHA GENE THERAPIES, INC. 2280 INWOOD ROAD DALLAS TX 75235 1 0 0 0 Stock Option (right to buy) 21.77 2020-11-23 4 A 0 31000 0.00 A 2030-11-23 Common Stock 31000 31000 D The shares subject to the Option vest in 36 equal monthly installments, subject to the Reporting Person continuing to provide service through each such date. /s/ Kamran Alam, Attorney-in-Fact 2020-11-24